The lateral septum is heavily implicated in anxiety regulation, with lesions or pharmacological inhibition of this region suppressing rats' defensive responses in various rat models of anxiety. My first objective was to explore the functional relationship between the lateral septum and its major afferent structure, the ventral hippocampus. Although these structures are extensively connected, it was not clear if they work in concert to regulate anxiety-like behaviours. This idea was tested using a pharmacological disconnection technique, whereby communication between these two structures was disabled by infusing the GABAA agonist muscimol into one side of the lateral septum and the contralateral side of the ventral hippocampus. Increases in open-arm exploration were evident when muscimol was co-infused into one side of the lateral septum and the contralateral ventral hippocampus. By contrast, open arm exploration was not altered when muscimol was co-infused into one side of the lateral septum and the ipsilateral ventral hippocampus. These results support the contention that the ventral hippocampus and the lateral septum regulate rats' open arm exploration in a serial fashion, and that this involves ipsilateral projections from the former to the latter site. My second objective was to further characterize the neuropharmacological aspects of lateral septal regulation of behavioural defence. The lateral septum contains high levels of NPY Y1 and Y2 receptor binding sites in the brain, yet little is known about their contribution in anxiety regulation at this site. Therefore, the second aim of my thesis was to characterize the contribution of NPY and its Y1 and Y2 receptor subtypes in the lateral septal regulation of anxiety in the elevated plus maze, novelty-induced suppression of feeding, and shock-probe burying tests. I determined that distinct NPY receptors differentially contribute to NPY-mediated anxiolysis in a test specific manner, with the Y1 receptor mediating NPY-induced anxiolysis in the novelty-induced suppression of feeding test, and the Y2 receptor mediating NPY13-36-induced anxiolysis in the plus-maze test. Taken together, the results from these studies reinforce the view that the regulation of anxiety involves a variety of different, yet overlapping neural processes. / Thesis (Ph.D, Neuroscience Studies) -- Queen's University, 2012-09-25 18:02:11.172

O núcleo basolateral anterior da amígdala (BLAa) tem sido extensivamente investigado em estudos de condicionamento pavloviano envolvendo estímulos aversivos físicos. Até o presente momento não há descrição funcional específica do BLAa frente aos estímulos etologicamente relevantes. Neste trabalho, inicialmente revisitamos as conexões aferentes e eferentes do BLAa. Nossos achados confirmam em grande medida relatos anteriores da literatura e mostram que o núcleo integra informações de sistemas relacionados ao alerta emocional (tais como o locus coeruleus, dorsal da rafe e substância inominada). Este também se relaciona intimamente a estruturas ligadas à circuitaria do córtex pré-frontal, como o núcleo acúmbens, o caudo-putamen dorsomedial além dos córtices pré-límbico e cingulado anterior. Além disso estabelece conexões bidirecionais importantes com o córtex insular e com a região para-hipocampal. Testamos ainda o papel específico do BLAa frente à ameaça predatória e vimos que este influencia respostas de medo inato e contextual à ameaça predatória. Primeiramente, sugerimos que o BLAa responde ao estímulo do predador pelos sistemas de controle de alerta emocional, dado que ele recebe aferências de estruturas responsivas à presença do predador, como o locus coeruleus, que estão ligadas ao controle do alerta. Sugerimos também que através de suas projeções para o núcleo acúmbens, a região estudada, possa influenciar as respostas de defesa inata. Ademais as respostas de medo aprendido, ao contexto em que o rato foi exposto ao predador, podem ser afetadas por meio das relações do BLAa com os córtices pré-limbico, cingulado anterior e com a região para-hipocampal. / The anterior basolateral nucleus of the amygdala (BLAa) has been extensively investigated in studies of Pavlovian conditioning involving physical aversive stimuli. To date, there is no specific functional study of the BLAa regarding its functional roles on responses to ethologically relevant threats. In this work, we initially revisited the afferent and efferent connections of the BLAa. Our findings largely confirm previous reports in the literature, and show that the nucleus integrates information from systems related to emotional alertness (such as the locus coeruleus, dorsal raphe and innominate substance), and is also closely related to the prefrontal cortex circuitry, including the nucleus accumbens, the dorsomedial caudoputamen, and the prelimbic and anterior cingulate cortices. It also establishes important bi-directional connections with the insular cortex and parahippocampal region. We also tested the specific role of BLAa in innate and contextual responses to predatory threat. Thus, we have seen that BLAa influences innate and contextual fear responses to predatory menace. Firstly, we suggest that the BLAa responds to the predator\'s stimulus by the emotional arousal systems, given that it receives inputs from alert related structures highly responsive to the predator threat, such as the locus coeruleus. We also suggest that through its projections to the nucleus accumbens, the BLAa may influence innate defensive responses. In addition, we suggested that the BLAa influences contextual fear responses mostly through its relationships with the prelimbic, anterior cingulate and parahippocampal cortices.

<p>A new group of anabolic androgenic steroid (AAS) users has developed during the last two decades. This group consists primarily of young men interested in improving their physical appearance. Within this group, AAS are sometimes used together with other illicit drugs, alcohol and nicotine. Brutal and violent crimes have been committed under the influence of AAS, possibly because of AAS psychiatric side effects, ranging from increased aggression and psychosis to depression. Unfortunately, the biochemical mechanisms behind these effects are poorly understood.</p><p>In this thesis we used an animal model to study biochemical and behavioural effects of chronic AAS treatment (15 mg/kg/day of nandrolone decanoate for 14 days). The effect on the endogenous opioid peptides and the expression of immediate-early gene protein Fos in various brain regions were studied using radioimmunoassay and immunohistochemistry, respectively. In addition, we studied AAS effect on voluntary alcohol consumption and defensive behaviours, including aggression. The results show that AAS enhance endogenous opioid activity and Fos expression in brain regions regulating reward, aggression and disinhibitory behaviours. An imbalance between two opioid systems with generally opposing effects, the enkephalins with euphoric and the dynorphins with dysphoric effects, was also found. This implies that AAS alter the ability to maintain a stable state of mind and the response to other drugs of abuse. The AAS pre-treated animals enhanced their alcohol intake, were more aggressive and showed lower fleeing and freezing reaction than the controls. In addition, AAS enhanced amphetamine-induced aggression when the amphetamine was given three weeks after the last AAS injection.</p><p>The behavioural and biochemical results found in this thesis, support the hypothesis that use of AAS might lead to the development of dependence and may induce changes in the brain leading to disinhibitory behaviours.</p>

A new group of anabolic androgenic steroid (AAS) users has developed during the last two decades. This group consists primarily of young men interested in improving their physical appearance. Within this group, AAS are sometimes used together with other illicit drugs, alcohol and nicotine. Brutal and violent crimes have been committed under the influence of AAS, possibly because of AAS psychiatric side effects, ranging from increased aggression and psychosis to depression. Unfortunately, the biochemical mechanisms behind these effects are poorly understood. In this thesis we used an animal model to study biochemical and behavioural effects of chronic AAS treatment (15 mg/kg/day of nandrolone decanoate for 14 days). The effect on the endogenous opioid peptides and the expression of immediate-early gene protein Fos in various brain regions were studied using radioimmunoassay and immunohistochemistry, respectively. In addition, we studied AAS effect on voluntary alcohol consumption and defensive behaviours, including aggression. The results show that AAS enhance endogenous opioid activity and Fos expression in brain regions regulating reward, aggression and disinhibitory behaviours. An imbalance between two opioid systems with generally opposing effects, the enkephalins with euphoric and the dynorphins with dysphoric effects, was also found. This implies that AAS alter the ability to maintain a stable state of mind and the response to other drugs of abuse. The AAS pre-treated animals enhanced their alcohol intake, were more aggressive and showed lower fleeing and freezing reaction than the controls. In addition, AAS enhanced amphetamine-induced aggression when the amphetamine was given three weeks after the last AAS injection. The behavioural and biochemical results found in this thesis, support the hypothesis that use of AAS might lead to the development of dependence and may induce changes in the brain leading to disinhibitory behaviours.